Baidu
map

Int J Environ Health Res:中国武汉学龄前儿童中家居装修与哮喘、过敏性鼻炎和湿疹的关系

2021-08-15 AlexYang MedSci原创

传统上,室内地板都是用陶瓷装饰的。近年来,随着居民生活水平的提高以及经济的快速发展和城市化进程,中国的建房和家庭装修越来越多,并且在最近建成的住宅楼中使用人工合成材料和家具也在增加。目前,

传统上,室内地板都是用陶瓷装饰的。近年来,随着居民生活水平的提高以及经济的快速发展和城市化进程,中国的建房和家庭装修越来越多,并且在最近建成的住宅楼中使用人工合成材料和家具也在增加。目前,中国的人造板、涂料和其他室内装饰材料的使用以及家具的生产都位居世界第一

近期,有研究人员调查了武汉市学龄前儿童中家庭装修与过敏性疾病之间的潜在关联

研究人员在2019年11月至12月期间对武汉市9455名3-6岁的学龄前儿童进行了一次大型横断面问卷调查。根据问卷调查结果,对人口统计学、健康状况和家庭装修条件等数据进行了分析。

研究结果发现,与瓷砖/石材/水泥地板覆盖物相比,使用复合地板会显著增加儿童诊断为鼻炎和湿疹的风险(鼻炎:AOR,95%CI:1.36,1.06-1.73;湿疹:AOR,95%CI:1.47,1.17-1.85)。 家庭装修与诊断的湿疹有明显的关联(怀孕前1年内:AOR,95%CI:1.34,1.20-1.50;怀孕期间:AOR,95%CI:1.25,1.08-1.44)。

综上所述,在儿童早期和怀孕期间使用人工合成材料进行家庭装修可能是儿童哮喘、过敏性鼻炎和湿疹的潜在风险因素

家庭装修材料,装修时间与儿童健康之间的相关性情况

这项研究为家庭装修暴露与学龄前儿童中的儿童哮喘、过敏性鼻炎和湿疹的高发率有显著关系提供了证据。不同的家庭装修材料对过敏性鼻炎和湿疹的患病率有不同的影响。人工合成材料比传统材料的风险相对更高。此外,在早期生活中的家庭装修增加了儿童哮喘、过敏性鼻炎和湿疹风险。

原始出处:

Xiaotong Ren , Yunhao Liu , Lian Hu et al. Associations between home renovation and asthma, allergic rhinitis, and eczema among preschool children in Wuhan, China. Int J Environ Health Res. Jul 2021

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2047439, encodeId=22f2204e43910, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Jul 26 05:37:02 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861465, encodeId=38dc186146572, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 18 19:37:02 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981243, encodeId=314419812432e, content=<a href='/topic/show?id=8a344564298' target=_blank style='color:#2F92EE;'>#学龄前儿童#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45642, encryptionId=8a344564298, topicName=学龄前儿童)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jul 29 10:37:02 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524332, encodeId=f8f51524332f3, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621925, encodeId=54231621925fe, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2047439, encodeId=22f2204e43910, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Jul 26 05:37:02 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861465, encodeId=38dc186146572, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 18 19:37:02 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981243, encodeId=314419812432e, content=<a href='/topic/show?id=8a344564298' target=_blank style='color:#2F92EE;'>#学龄前儿童#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45642, encryptionId=8a344564298, topicName=学龄前儿童)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jul 29 10:37:02 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524332, encodeId=f8f51524332f3, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621925, encodeId=54231621925fe, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2022-01-18 shizhenshan
  3. [GetPortalCommentsPageByObjectIdResponse(id=2047439, encodeId=22f2204e43910, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Jul 26 05:37:02 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861465, encodeId=38dc186146572, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 18 19:37:02 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981243, encodeId=314419812432e, content=<a href='/topic/show?id=8a344564298' target=_blank style='color:#2F92EE;'>#学龄前儿童#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45642, encryptionId=8a344564298, topicName=学龄前儿童)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jul 29 10:37:02 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524332, encodeId=f8f51524332f3, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621925, encodeId=54231621925fe, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2047439, encodeId=22f2204e43910, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Jul 26 05:37:02 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861465, encodeId=38dc186146572, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 18 19:37:02 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981243, encodeId=314419812432e, content=<a href='/topic/show?id=8a344564298' target=_blank style='color:#2F92EE;'>#学龄前儿童#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45642, encryptionId=8a344564298, topicName=学龄前儿童)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jul 29 10:37:02 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524332, encodeId=f8f51524332f3, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621925, encodeId=54231621925fe, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-08-17 july_979
  5. [GetPortalCommentsPageByObjectIdResponse(id=2047439, encodeId=22f2204e43910, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Jul 26 05:37:02 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861465, encodeId=38dc186146572, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Tue Jan 18 19:37:02 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981243, encodeId=314419812432e, content=<a href='/topic/show?id=8a344564298' target=_blank style='color:#2F92EE;'>#学龄前儿童#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45642, encryptionId=8a344564298, topicName=学龄前儿童)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Jul 29 10:37:02 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524332, encodeId=f8f51524332f3, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621925, encodeId=54231621925fe, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Aug 17 09:37:02 CST 2021, time=2021-08-17, status=1, ipAttribution=)]

相关资讯

Allergy Asthma Clin Immunol:皮下过敏原免疫疗法的全身反应

皮下免疫疗法(SCIT)为几种常见的过敏性疾病提供了有效的疾病治疗疗法。在治疗过敏性鼻炎、过敏性结膜炎、过敏性哮喘和昆虫过敏方面,SCIT的安全性和有效性已经得到证实。对于有气源性过敏原过敏的特应性皮

Am J Rhinol Allergy:次氯酸与生理盐水鼻腔冲洗在过敏性鼻炎中的应用

过敏性鼻炎(AR)是全球最常见的慢性疾病之一,主要症状包括鼻塞、流鼻涕、打喷嚏和瘙痒。它的特点是鼻粘膜上的Th2免疫介导的超敏反应状况。在免疫学上,AR与鼻粘膜中嗜酸细胞和肥大细胞的浸润增加以及血清中

Am J Transl Res:玉屏风散联合氯雷他定治疗小儿过敏性鼻炎的临床疗效

临床上,小儿变应性鼻炎(PAR)又称过敏性鼻炎(AR),是以鼻腔黏膜充血为特征的一种慢性炎症性疾病,其发病率非常高。过敏性鼻炎的主要临床症状为夜间突然咳嗽、后鼻滴、鼻塞、流涕、打喷嚏、鼻痒。AR的病原

Asian Pac J Allergy Immunol:富马酸卢帕他定治疗常年过敏性鼻炎的疗效和安全性

卢帕他定治疗AR的疗效已在许多临床研究中得到证实,但对亚洲患者的研究非常少。

Allergy Asthma Clin Immunol:治疗树花粉引起的季节性过敏性鼻炎的成本最小化选择:舌下免疫治疗药片

近期,有研究人员进行了成本最小化分析(CMA),评估了在加拿大(安大略省和魁北克省)引入SQ树舌下免疫疗法(SLIT)药片的经济情况,该片剂以ITULATEK®上市(2020年4月获得加拿大卫

Can Respir J:MicroRNA-155作为儿童过敏性鼻炎潜在生物标志物的作用调查

过敏性鼻炎(AR)是最常见的非感染性慢性鼻炎,在世界范围内发病率很高,影响40%的人口。AR的症状包括鼻出血、打喷嚏、鼻痒和鼻塞,这是由于暴露于过敏原,如螨虫、昆虫、花粉、烟草烟雾以及阿司匹林或其他非

Baidu
map
Baidu
map
Baidu
map